The updated guidelines recommend, in brief:
- Either cognitive behavioral therapy (CBT) or second-generation antidepressants (SGAs) as first-line monotherapy in the acute phase
- Combination of both therapies in the acute phase as a third choice
- CBT monotherapy in the acute phase of mild MDD
- In non-responding patients on SGAs, add or change to CBT, change SGA, or add a second drug